Product Images Olanzapine
View Photos of Packaging, Labels & Appearance
- olanzapine orally disintegrating tablet image 01 - db8f0636 7155 4040 8ab5 a35e380d98f9 01
- Olanzapine odt image 02 - db8f0636 7155 4040 8ab5 a35e380d98f9 02
- olanzapine odt image 03 - db8f0636 7155 4040 8ab5 a35e380d98f9 03
- olanzapine odt image 04 - db8f0636 7155 4040 8ab5 a35e380d98f9 04
- olanzapine odt image 04 - db8f0636 7155 4040 8ab5 a35e380d98f9 05
Product Label Images
The following 5 images provide visual information about the product associated with Olanzapine NDC 68382-519 by Zydus Pharmaceuticals Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Olanzapine odt image 02 - db8f0636 7155 4040 8ab5 a35e380d98f9 02

This text provides information about Olanzapine Orally Disintegrating Tablets, USP, with NDC number 68382-516-10. Each tablet contains 5g of Olanzapine. It is recommended to refer to the package insert for complete dosing information, especially for phenylketonurics as the tablet contains phenylalanine. The storage conditions are specified to be kept between 15-25°C (59-77°F) in a USP Controlled Room Temperature. It is advised to protect the tablets from moisture and dispense them in a tight, light-resistant container. The text emphasizes keeping the medication out of the reach of children. The manufacturing information is for Cadila Healthcare Limited, while distribution is by Zydus Pharmaceuticals USA Inc. located in Pennington, 106534.*
olanzapine odt image 04 - db8f0636 7155 4040 8ab5 a35e380d98f9 04

This text includes details about a medication called Olanzapine Orally Disintegrating Tablets, including dosage information and storage instructions. It mentions protecting the tablets from light and dispensing in a tightly closed container. The label also includes a warning to keep the medication out of reach of children. The text further indicates that the tablets are distributed by Zydus Pharmaceuticals USA in New Jersey, USA.*
olanzapine odt image 04 - db8f0636 7155 4040 8ab5 a35e380d98f9 05

The text provides information about Olanzapine Orally Disintegrating Tablets, which is used for the treatment of mental health disorders. It includes details such as the manufacturer, Cadila Healthcare Ltd, from Ahmedabad, India, and a contact address in the USA for Pharmaceutical USA. Additionally, the text mentions the number of tablets in the package, which is 1000, and that it is prescription-only medication.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.